Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ABI 1179

Next Previous
X
Search
Drug Profile

ABI 1179

Alternative Names: ABI-1179

Latest Information Update: 06 Dec 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Gilead Sciences
  • Developer Assembly Biosciences
  • Class Antivirals; Small molecules
  • Mechanism of Action DNA helicase-primase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Herpes simplex virus infections

Most Recent Events

  • 11 Nov 2024 Assembly Biosciences plans a phase I trial for Herpes simplex virus infection in New Zealand (PO) (NCT06698575)
  • 15 Jul 2024 Pharmacodynamics and pharmacokinetics data from a preclinical study in Herpes simplex virus infection released by Assembly Biosciences
  • 04 Apr 2024 Assembly Biosciences plans a clinical trial for ABI 1179 by the end of 2024 (ASSEMBLY BIOSCIENCES_10-K_SEC-filing_Dec-2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top